Witt CA on Muck Rack

Witt CA

As seen in: European Respiratory Review
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Witt

Contact Witt, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Tocilizumab for Antibody Mediated Rejection Treatment in Lung Transplantation

|
By Derek Byers, Witt CA, January SE, Halverson LP
| ncbi.nlm.nih.gov
Save citation to file Format: Add to My Bibliography Your saved search Name of saved search: Search terms: Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Create a file for external citation management software
Open in Who Shared View Duplicates (603) Issue with article?

Lung transplantation for interstitial lung disease

|
By Tague LK, Witt CA, Byers DE
| European Respiratory Review Verified
Siddhartha G. Kapnadak, Ganesh Raghu European Respiratory Review 2021 30: 210017; DOI: 10.1183/16000617.0017-2021 Abstract Lung transplantation (LTx) can be a life-extending treatment option for patients with advanced and/or progressive fibrotic interstitial lung disease (ILD), especially idiopathic pulmonary fibrosis (IPF), fibrotic hypersensitivity pneumonitis, sarcoidosis and connective tissue disease-associated ILD. IPF is now the most common indication for LTx worldwide.
Open in Who Shared Issue with article?
See all 2 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified